(MedPage Today) -- A MedPage Today/Milwaukee Journal Sentinel report revealed the staggering annual treatment cost for the cystic fibrosis drug ivacaftor (Kalydeco) as part of an investigation of venture philanthrophy -- now a JAMA Viewpoint echoes those findings. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment